Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (30)

2021

  1. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2013

  1. Neuronal excitotoxicity after carotid angioplasty and stent placement procedures

    Radiology, Vol. 268, Núm. 2, pp. 515-520

2012

  1. Cumplimiento de las medidas de prevención de factores de riesgo vascular en pacientes ingresados con ictus agudo. análisis de un registro multicéntrico: Registro epices (III)

    Revista de Neurologia, Vol. 54, Núm. 9, pp. 523-529

  2. Epidemiología de los subtipos de ictus en pacientes hospitalizados atendidos por neurólogos: Resultados del registro EPICES (I)

    Revista de Neurologia, Vol. 54, Núm. 7, pp. 385-393

  3. Réplica 1

    Revista de Neurologia, Vol. 55, Núm. 5, pp. 319-320

  4. Tiempos de llegada al hospital y hasta la atención neurológica de pacientes con ictus agudo. Análisis de un registro multicéntrico nacional: Registro epices (II)

    Revista de Neurologia, Vol. 54, Núm. 8, pp. 461-467

  5. Usefulness of material recovered from distal embolic protection devices after carotid angioplasty for proteomic studies

    Journal of Vascular and Interventional Radiology, Vol. 23, Núm. 6, pp. 818-824

2011

  1. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

2010

  1. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: How well are we correcting it?: Implications for outcome

    Stroke, Vol. 41, Núm. 10, pp. 2362-2365

  2. Stroke with polyvascular atherothrombotic disease

    Atherosclerosis, Vol. 208, Núm. 2, pp. 587-592

2009

  1. Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. on behalf of Spains REACH Registry

    Medicina Clinica, Vol. 132, Núm. 14, pp. 537-544

  2. Inflammation markers and prediction of post-stroke vascular disease recurrence: The MITICO study

    Journal of Neurology, Vol. 256, Núm. 2, pp. 217-224

2008

  1. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment

    Disease Markers, Vol. 25, Núm. 3, pp. 181-188

  2. Body temperature and response to thrombolytic therapy in acute ischaemic stroke

    European Journal of Neurology, Vol. 15, Núm. 12, pp. 1384-1389

  3. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA

    Stroke, Vol. 39, Núm. 7, pp. 2006-2010

  4. Marcadores moleculares asociados a signos precoces de isquemia en tomografía computarizada cerebral

    Neurologia, Vol. 23, Núm. 4, pp. 220-225

2007

  1. Control de factores de riesgo y tratamiento de la aterotrombosis. Registro REACH España

    Medicina Clinica, Vol. 129, Núm. 12, pp. 446-450

  2. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke

    Stroke, Vol. 38, Núm. 1, pp. 90-95

  3. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study

    Stroke, Vol. 38, Núm. 6, pp. 1855-1859